American Heart Journal
Volume 150, Issue 2 , Pages 209-214 , August 2005

Blood glucose: A strong risk factor for mortality in nondiabetic patients with cardiovascular disease

  • Sidney C. Port, PhD

      Affiliations

    • Department of Statistics, University of California Los Angeles, Calif
    • Department of Mathematics, University of California Los Angeles, Calif
    • Corresponding Author InformationReprint requests: Sidney C. Port, PhD, Department of Mathematics, University of California Los Angeles, Los Angeles, CA 90095-1555.
    • ,
  • Mark O. Goodarzi, MD, PhD

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center and Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Calif
    • ,
  • Noel G. Boyle, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Calif
    • ,
  • Robert I. Jennrich, PhD

      Affiliations

    • Department of Statistics, University of California Los Angeles, Calif

Received 5 May 2004 ,Accepted 20 September 2004.

References 

  1. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146
  2. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322:15–18
  3. Marso SP. Optimizing the diabetic formulary: beyond aspirin and insulin. J Am Coll Cardiol. 2002;40:652–661
  4. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937–942
  5. Gerstein HC, Pais P, Pogue J, et al. Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. J Am Coll Cardiol. 1999;33:612–619
  6. Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233–240
  7. Bjornholt JV, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care. 1999;22:45–49
  8. Donahue RP, Abbott RD, Reed DM, et al. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987;36:689–692
  9. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999;22:920–924
  10. Balkau B, Bertrais S, Ducimetiere P, et al. Is there a glycemic threshold for mortality risk?. Diabetes Care. 1999;22:696–699
  11. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  12. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care. 2001;24:1634–1639
  13. Zeller M, Cottin Y, Brindisi MC, et al. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J. 2004;25:308–312
  14. Fisman EZ, Motro M, Tenenbaum A, et al. Impaired fasting glucose concentration in non-diabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J. 2001;141:485–490
  15. Muhlestein JB, Anderson JL, Horne BD, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146:351–358
  16. Arcavi L, Behar S, Caspi A, et al. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary heart disease: results from the Bezafibrate Infarction Prevention (BIP) study. Am Heart J. 2004;147:239–245
  17. Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge: Harvard University Press; 1980;
  18. Nelson NA. Photometric adaptation of the Somogyi method for the determination of glucose. J Biol Chem. 1944;153:375–380
  19. Kuwa K, Nakayama T, Hoshino T, et al. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta. 2001;307:187–192
  20. Cupples LA, D'Agostino RB, Anderson K, et al. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med. 1988;7:205–222
  21. D'Agostino RB, Lee ML, Belanger AJ, et al. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501–1515
  22. King GL, Wakasaki H. Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care. 1999;22(Suppl 3):C31–C37
  23. Pyorala M, Miettinen H, Laakso M, et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998;98:398–404
  24. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155–158
  25. Jokl R, Laimins M, Klein RL, et al. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994;17:818–823
  26. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-Year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998;21:360–367
  27. Wei M, Gibbons LW, Mitchell TL, et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation. 2000;101:2047–2052

PII: S0002-8703(04)00663-5

doi: 10.1016/j.ahj.2004.09.031

American Heart Journal
Volume 150, Issue 2 , Pages 209-214 , August 2005

Article Tools

* Image Usage & Resolution